Sadiq Ahmed

h-index

Research activity per year

Education/Academic qualification

Residency, University Of Connecticut

1998

Residency, Mymensingh Medical College, Mymensing Bangladesh

1990

Bachelor of Medicine, Bachelor of Surgery, University Of Dhaka

1989

Fingerprint

Dive into the research topics where Sadiq Ahmed is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1 Finished
2 Active

Rapcabtagene: A Phase 2, Adaptive, Randomized, Open-Label, Assessor-Blinded Active-Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel vs. SOC in Patients Suffering from Systemic Lupus Erythematosus (SLE) with Active, Refractor
Piranavan, P. (PI), Ahmed, S. (CoI), Alkilany, R. (CoI) & Qasrawi, A. (CoI)
Novartis (domestic)
11/8/24 → 12/21/30
Project: Research project
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Proliferative Lupus Nephritis or Immunoglobulin A Nephropathy
Ahmed, S. (PI)
Syneos Health LLC
7/1/21 → 1/29/26
Project: Research project
A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants Who Have Thrombotic Microangiopathy Associated With a Trigger
Ahmed, S. (PI)
Alexion Pharmaceuticals
7/31/21 → 5/2/23
Project: Research project

1 Article

Rare case of losartan-induced cough complicated by rectus sheath haematoma: in a patient on rivaroxaban therapy
Talari, G., Talari, P., Sweigart, J. & Ahmed, S., Dec 23 2016, In: BMJ Case Reports. 2016
Research output: Contribution to journal › Article › peer-review
7 Citations (SciVal)

Sadiq Ahmed

Personal profile

Education/Academic qualification

Fingerprint

Projects & Grants

Rapcabtagene: A Phase 2, Adaptive, Randomized, Open-Label, Assessor-Blinded Active-Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel vs. SOC in Patients Suffering from Systemic Lupus Erythematosus (SLE) with Active, Refractor

A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Proliferative Lupus Nephritis or Immunoglobulin A Nephropathy

A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants Who Have Thrombotic Microangiopathy Associated With a Trigger

Research output

Rare case of losartan-induced cough complicated by rectus sheath haematoma: in a patient on rivaroxaban therapy